Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology
This trial has been completed.
|Treatment||cognitive evaluation by mms (mini-mental state examination) and moca (montreal cognitive assessment) tests|
|Sponsor||Centre Francois Baclesse|
|Start date||September 2015|
|End date||March 2017|
|Trial size||66 participants|
|Trial identifier||NCT02558907, MoCA|
Compare neurocognitive testing MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) to candidates aged patients with 1st line treatment of their cancer will be received an examination oncogériatric
proportion of patients with cognitive disorders identified by the MoCA or the MMSE prior to treatment
time frame: before their first treatment for the cancer, at inclusion
All participants at least 71 years old.
Inclusion Criteria: - Patient old over 70 years - Patient with cancer (solid tumor or hematological) for which a 1st line treatment is planned - Patient candidate an oncogeriatric assessment - Patient agreeing to participate in the study - French language - Lack of subsequent neurological sequelae with cognitive impact stroke, dementia or progressive psychiatric disorder - Patient having a life expectancy ≥ 6 months Exclusion Criteria: - Primitive cancer of the central nervous system or brain metastasis - Patients unable to meet the cognitive tests - Refusal to participate - Realization of a MMSE or MoCA test in the last 6 months
|Official title||Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology|
|Principal investigator||Heidi LAVIEC, MD|
Call for more information